Who owns Scinai Immunotherapeutics Ltd, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
LCK JNK 1 LLC: 6.3% · 317,366 shares
STONE DANIEL E.: 9.9% · 0 shares — RK Stone Miami, LLC: 7.1% · 0 shares
2 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of Scinai Immunotherapeutics Ltd.
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Scinai Immunotherapeutics Ltd they hold. Together these 21 managers report 0.00% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| ENVESTNET ASSET MANAGEMENT INC | $58K | 79,216 | 0.00% | 0.00% | September 30, 2022 |
| TWO SIGMA SECURITIES, LLC | $38K | 22,922 | 0.00% | 0.00% | March 31, 2022 |
19 more institutional holders behind a free account
See every manager reporting Scinai Immunotherapeutics Ltd, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 4 funds hold 0.00% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| PMC Diversified Equity Fund | $180K | 0.02% | 0.00% | August 31, 2022 |
| Fidelity Nasdaq Composite Index Fund | $15.1K | 0.00% | 0.00% | August 31, 2022 |
2 more funds behind a free account
See every fund holding Scinai Immunotherapeutics Ltd and what share of its net assets the position represents.
Sign up freeLoading...
